Telos Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Telos Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.44M	Sell	111,780 -4,308	-4%	-$247K	0.57%	65
2026 Q1	$7.04M	Buy	116,088 +66	+0.1%	+$3.85K	0.67%	57
2025 Q4	$6.26M	Buy	116,022 +302	+0.3%	+$14.5K	0.58%	69
2025 Q3	$5.22M	Buy	115,720 +2,269	+2%	+$106K	0.5%	74
2025 Q2	$5.25M	Buy	113,451 +3,739	+3%	+$184K	0.53%	72
2025 Q1	$6.69M	Sell	109,712 -700	-0.6%	-$40.8K	0.73%	51
2024 Q4	$6.24M	Buy	110,412 +3,985	+4%	+$223K	0.67%	58
2024 Q3	$5.51M	Buy	106,427 +1,377	+1%	+$64.6K	0.58%	71
2024 Q2	$4.36M	Sell	105,050 -1,638	-2%	-$73.3K	0.48%	75
2024 Q1	$5.79M	Sell	106,688 -85,571	-45%	-$4.36M	0.65%	55
2023 Q4	$9.86M	Sell	192,259 -68,245	-26%	-$3.58M	1.2%	27
2023 Q3	$15.1M	Buy	260,504 +5,483	+2%	+$336K	2.1%	8
2023 Q2	$16.3M	Buy	255,021 +8,746	+4%	+$586K	2.17%	7
2023 Q1	$17.1M	Buy	246,275 +6,639	+3%	+$468K	2.38%	5
2022 Q4	$17.2M	Buy	239,636 +8,073	+3%	+$609K	2.51%	4
2022 Q3	$16.5M	Sell	231,563 -551	-0.2%	-$40K	2.71%	4
2022 Q2	$17.9M	Sell	232,114 -8,982	-4%	-$684K	2.73%	4
2022 Q1	$17.6M	Sell	241,096 -3,219	-1%	-$216K	2.29%	4
2021 Q4	$15.2M	Buy	244,315 +9,986	+4%	+$586K	1.9%	7
2021 Q3	$13.9M	Buy	234,329 +15,575	+7%	+$1.03M	1.9%	8
2021 Q2	$14.6M	Buy	218,754 +6,343	+3%	+$414K	1.93%	7
2021 Q1	$13.4M	Buy	212,411 +2,084	+1%	+$130K	1.93%	7
2020 Q4	$13M	Buy	210,327 +6,954	+3%	+$428K	1.98%	7
2020 Q3	$12.2M	Buy	203,373 +6,175	+3%	+$372K	2.13%	6
2020 Q2	$11.6M	Buy	197,198 +66,335	+51%	+$3.97M	2.24%	5
2020 Q1	$7.25M	Buy	130,863 +29,038	+29%	+$1.77M	1.8%	10
2019 Q4	$6.54M	Buy	101,825 +90,028	+763%	+$5.16M	1.49%	11
2019 Q3	$598K	Buy	11,797 +719	+6%	+$33.8K	0.16%	110
2019 Q2	$502K	Buy	11,078 +1,002	+10%	+$46.7K	0.15%	110
2019 Q1	$480K	Sell	10,076 -353	-3%	-$17.6K	0.15%	107
2018 Q4	$542K	Sell	10,429 -317	-3%	-$17K	0.2%	100
2018 Q3	$668K	Sell	10,746 -1,537	-13%	-$91.2K	0.21%	96
2018 Q2	$680K	Sell	12,283 -2,461	-17%	-$133K	0.23%	92
2018 Q1	$933K	Buy	14,744 +635	+5%	+$40.9K	0.33%	87
2017 Q4	$864K	Sell	14,109 -119	-0.8%	-$7.44K	0.31%	89
2017 Q3	$907K	Buy	14,228 +18	+0.1%	+$1.05K	0.35%	85
2017 Q2	$792K	Buy	14,210 +2,258	+19%	+$123K	0.32%	89
2017 Q1	$650K	Buy	11,952 +4,580	+62%	+$251K	0.27%	98
2016 Q4	$431K	Buy	7,372 +160	+2%	+$8.75K	0.19%	105
2016 Q3	$389K	Buy	7,212 +1,050	+17%	+$67.4K	0.18%	109
2016 Q2	$453K	Sell	6,162 -300	-5%	-$21.2K	0.22%	104
2016 Q1	$413K	Sell	6,462 -158	-2%	-$9.96K	0.22%	102
2015 Q4	$455K	Hold	6,620	–	–	0.25%	103
2015 Q3	$392K	Hold	6,620	–	–	0.24%	105
2015 Q2	$440K	Buy	+6,620	New	+$436K	0.24%	102

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Telos Capital Management's BMY Position: Q2 2026 in Review

Telos Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 3.7% in Q2 2026, selling an estimated $247K and leaving 111,780 shares worth $6.44M. The position accounts for 0.57% of the portfolio, ranked #65.

Telos Capital Management first reported a position in BMY in Q2 2015 and has held it in 45 quarters since. The position peaked at $17.9M in Q2 2022. 814 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Telos Capital Management held 111,780 shares of Bristol-Myers Squibb worth $6.44M as of Q2 2026.
Telos Capital Management sold 4,308 Bristol-Myers Squibb shares in Q2 2026, an estimated $247K.
Bristol-Myers Squibb made up 0.57% of Telos Capital Management's portfolio in Q2 2026, its #65 holding.
Telos Capital Management first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 45 quarters since.
Telos Capital Management's Bristol-Myers Squibb position peaked at $17.9M in Q2 2022.
814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Telos Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.